These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 16923657)
1. Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies. Ramaswamy K; Masand PS; Nasrallah HA Ann Clin Psychiatry; 2006; 18(3):183-94. PubMed ID: 16923657 [TBL] [Abstract][Full Text] [Related]
2. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims. Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516 [TBL] [Abstract][Full Text] [Related]
3. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575 [TBL] [Abstract][Full Text] [Related]
4. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia. Ollendorf DA; Joyce AT; Rucker M MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database. Gianfrancesco FD; Grogg AL; Mahmoud RA; Wang RH; Nasrallah HA J Clin Psychiatry; 2002 Oct; 63(10):920-30. PubMed ID: 12416602 [TBL] [Abstract][Full Text] [Related]
6. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Henderson DC; Cagliero E; Copeland PM; Borba CP; Evins AE; Hayden D; Weber MT; Anderson EJ; Allison DB; Daley TB; Schoenfeld D; Goff DC Arch Gen Psychiatry; 2005 Jan; 62(1):19-28. PubMed ID: 15630069 [TBL] [Abstract][Full Text] [Related]
7. Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine. Yasui-Furukori N; Sato Y; Furukori H; Saito M; Nakagami T; Kaneko S J Clin Psychiatry; 2009 Jan; 70(1):95-100. PubMed ID: 19026267 [TBL] [Abstract][Full Text] [Related]
8. Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature. Vuk A; Kuzman MR; Baretic M; Osvatic MM Psychiatr Danub; 2017 Jun; 29(2):121-135. PubMed ID: 28636569 [TBL] [Abstract][Full Text] [Related]
9. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. Newcomer JW CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156 [TBL] [Abstract][Full Text] [Related]
10. The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy. Gianfrancesco F; Wang RH; Nasrallah HA Ann Clin Psychiatry; 2006; 18(1):9-17. PubMed ID: 16517448 [TBL] [Abstract][Full Text] [Related]
12. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652 [TBL] [Abstract][Full Text] [Related]
13. Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases. Rachid F; Bertschy G; Bondolfi G; Aubry JM J Clin Psychiatry; 2004 Nov; 65(11):1537-45. PubMed ID: 15554769 [TBL] [Abstract][Full Text] [Related]
14. A regional comparison of developing diabetes among VA patients exposed to typical and atypical antipsychotics relative to corticosteroids and proton pump inhibitors. Barnett M; Argo T; Alexander B; Perry P Ann Clin Psychiatry; 2006; 18(1):1-7. PubMed ID: 16517447 [TBL] [Abstract][Full Text] [Related]
15. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone]. Bret P; Bonnet F; Bret MC; Jaffré A Encephale; 2002; 28(4):329-42. PubMed ID: 12232542 [TBL] [Abstract][Full Text] [Related]
16. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study. Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671 [TBL] [Abstract][Full Text] [Related]
18. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Leslie DL; Rosenheck RA Am J Psychiatry; 2004 Sep; 161(9):1709-11. PubMed ID: 15337666 [TBL] [Abstract][Full Text] [Related]
19. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics. Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders. Gianfrancesco F; Grogg A; Mahmoud R; Wang RH; Meletiche D Clin Ther; 2003 Apr; 25(4):1150-71. PubMed ID: 12809963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]